REGULATED PRESS RELEASE published on 01/12/2024 at 17:45, 8 months 6 days ago MEDESIS PHARMA : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE S2 2023
ARTICLE published on 12/20/2023 at 18:46, 8 months 29 days ago Medesis Pharma augmente son capital pour soutenir le développement de traitements innovants Dans un contexte de sauvegarde, Medesis Pharma lève des fonds visant à financer la recherche contre la maladie d'Alzheimer Medesis Pharma Biotechnologie Pharmaceutique Augmentation De Capital Alzheimer Aonys®
REGULATED PRESS RELEASE published on 12/20/2023 at 18:00, 8 months 29 days ago MEDESIS PHARMA : Apport en trésorerie
REGULATED PRESS RELEASE published on 10/27/2023 at 18:00, 10 months 22 days ago MEDESIS PHARMA: 2023 FIRST-HALF BUSINESS AND EARNINGS
REGULATED PRESS RELEASE published on 10/27/2023 at 18:00, 10 months 22 days ago MEDESIS PHARMA : RAPPORT FINANCIER SEMESTRIELS 2023
REGULATED PRESS RELEASE published on 10/27/2023 at 18:00, 10 months 22 days ago MEDESIS PHARMA : ACTIVITÉS & RÉSULTATS DU 1ER SEMESTRE 2023
REGULATED PRESS RELEASE published on 10/23/2023 at 18:00, 10 months 26 days ago MEDESIS PHARMA PARTICIPE AU 16ème CONGRÈS INTERNATIONAL « CLINICAL TRIALS ON ALZHEIMER DISEASE » (CTAD) À BOSTON DU 24 AU 27 OCTOBRE 2023 ET PRÉSENTE UN POSTER SUR SA RECHERCHE EN COURS
REGULATED PRESS RELEASE published on 10/23/2023 at 18:00, 10 months 26 days ago MEDESIS PHARMA PARTICIPATES IN THE 16th INTERNATIONAL CONGRESS “CLINICAL TRIALS ON ALZHEIMER DISEASE” (CTAD) IN BOSTON FROM OCTOBER 24 TO 27, 2023 AND PRESENTS A POSTER ON ITS CURRENT RESEARCH
REGULATED PRESS RELEASE published on 10/17/2023 at 08:00, 11 months 1 day ago FIN DU RECRUTEMENT DES 68 PATIENTS DANS L’ÉTUDE CLINIQUE DE PHASE 2 DE MEDESIS PHARMA SUR LE NANOLITHIUM POUR LE TRAITEMENT DE LA MALADIE D’ALZHEIMER
REGULATED PRESS RELEASE published on 10/17/2023 at 08:00, 11 months 1 day ago END OF ENROLLEMENT OF THE 68 PATIENTS IN MEDESIS PHARMA PHASE 2 CLINICAL STUDY OF NANOLITHIUM FOR THE TREATMENT OF ALZHEIMER’S DISEASE
Published on 09/18/2024 at 23:10, 3 hours 52 minutes ago Ur-Energy Provides Operations, Construction and 2024 Guidance Updates
Published on 09/18/2024 at 23:00, 4 hours 2 minutes ago Garden State Gold & Coin Applauds Passage of Historic NJ Sales Tax Bill on Precious Metals
Published on 09/18/2024 at 21:15, 5 hours 47 minutes ago New to the Street Launches 24-Part Series with ARAX Holdings, Spotlighting Core Blockchain, CorePass, Lunaº Mesh, and Revolutionary Tech Solutions
Published on 09/18/2024 at 21:00, 6 hours 2 minutes ago Falcon Commences Drilling At Its Great Burnt Copper Project, NL
Published on 09/18/2024 at 16:30, 10 hours 32 minutes ago Manimal Tales Launches New Nursery Rhyme Based Detective Series: Your Child Solves Nursery Crimes in our Newest Personalized Book!
Published on 09/18/2024 at 19:11, 7 hours 51 minutes ago EQS-Adhoc: alstria office REIT-AG: squeeze-out demand regarding the shares of minority shareholders, amendment to investment agreement, loss of REIT-status at year-end 2024
Published on 09/18/2024 at 18:45, 8 hours 17 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/18/2024 at 18:31, 8 hours 30 minutes ago EQS-Adhoc: Vonovia SE: Initiation of the process to conclude a domination and profit and loss transfer agreement between Vonovia SE and Deutsche Wohnen SE
Published on 09/18/2024 at 18:13, 8 hours 49 minutes ago BILENDI: Creating discussion guides for market research is now possible with AI, thanks to BARI and Bilendi Discuss
Published on 09/18/2024 at 17:21, 9 hours 40 minutes ago EQS-Adhoc: Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 154,053 no-par value bearer shares at an issue price of EUR 5 per share
Published on 09/18/2024 at 18:45, 8 hours 16 minutes ago Augmentation de capital consécutive à l'attribution gratuite d'actions aux salariés du groupe EuropaCorp
Published on 09/18/2024 at 18:45, 8 hours 16 minutes ago Capital increase following the allocation of free shares to EuropaCorp employees
Published on 09/18/2024 at 17:40, 9 hours 22 minutes ago Groupe CRIT : Modalités de mise à disposition du Rapport Financier semestriel 2024.